The biology of circulating microRNAs in cardiovascular disease
European Journal of Clinical Investigation2015Vol. 45(8), pp. 860–874
Citations Over TimeTop 10% of 2015 papers
Abstract
Over recent years, increasing attention has been paid to the role of circulating miRNAs in cardiovascular disease. As biomarkers and intercellular communicators, circulating miRNAs could play important roles in the prediction, diagnosis and tailored treatment of cardiovascular diseases in the near future.
Related Papers
- → Regulated delivery of molecular cargo to invasive tumour-derived microvesicles(2015)176 cited
- → Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability(2012)97 cited
- → miR-200a targets Gelsolin: A novel mechanism regulating secretion of microvesicles in hepatocellular carcinoma cells(2017)28 cited
- → Inhibitory effect of microvesicles collected from stored blood on platelet aggregation(1981)5 cited
- ADVANCES IN TECHNOLOGIES FOR PURIFICATION AND ENRICHMENT OF EXTRACELLULAR VESICLES.(2019)